PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

Tower Cold Chain and Cold Chain Technologies Strengthen Global Reach with Expanded Hub Network

Tower Cold Chain, a Cold Chain Technologies company, a leading provider of passive temperature-controlled containers, has expanded its global footprint following its recent acquisition by Cold Chain Technologies (CCT). This strategic integration enhances both companies’ capabilities, offering a comprehensive network of temperature-controlled solutions to meet the growing global demand for pharmaceutical and life sciences shipments.

With the combined resources of Tower and CCT, customers now benefit from a vastly expanded hub network featuring three Centres of Excellence and 54 regional hubs spanning 26 countries, enabling broader geographic coverage and enhanced customer service.

Ahead of the acquisition, Tower Cold Chain had recently launched new hubs in Toronto, Canada, and Hyderabad, India, strengthening its presence across the Americas and Asia-Pacific regions.

Tower’s presence in regions such as South America and parts of APAC has now been significantly bolstered through CCT’s robust infrastructure. This expansion empowers customers to access a broader portfolio of solutions, combining Tower’s advanced reusable passive containers with CCT’s reliable single-use packaging options.

For Cold Chain Technologies, the acquisition strengthens its position in the EMEA region, where Tower Cold Chain already had a strong foothold.

The newly strengthened network not only boosts logistics efficiency but also advances the company’s sustainability goals by reducing idle time and minimising transport distances for reusable containers. Customers now benefit from improved regional support, faster delivery times, and streamlined product return processes, ensuring a more seamless and sustainable service experience.

Niall Balfour, CEO of Tower Cold Chain, commented: “We are delighted to provide our customers with greater availability and proximity of our expanded range of products and services through our strengthened global hub network.

“This development not only enhances our reach but also reinforces our commitment to delivering high-performance, temperature-controlled solutions with both global scalability and local expertise.

“After what was already a very successful year for Tower Cold Chain, the acquisition marks a significant milestone, positioning us for continued success as we head into 2025.”

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026